Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): could this be a new predictive biomarker in TTP?. Kuhlman P, Miller P, Farland A, Owen J, Batt K.. J Clin Apher. 2018;():.
Hemolytic anemia in two patients with glioblastoma multiforme: a possible interaction between vorinostat and dapsone. Lewis JA, Petty WJ, Harmon M, Peacock JE, Valente K, Owen J, Pirmohamed M, Lesser GJ.. J Oncol Pharm Pract. 2015;21(3):220-223.
Hypoxia and neoplasms: sickle cell patients as a living model [abstract]. Batt K, Isom S, Farland AM, Leedy D, Owen J, Bonomi MR.. J Clin Oncol. 2015;33(15 Suppl):e12591.
Hydroxyurea in sickle cell patients: a look at the correlation with hematologic malignancies [abstract]. Batt K, Isom S, Farland AM, Leedy D, Owen J, Bonomi MR.. J Clin Oncol. 2015;33(15 Suppl):e12593.
Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J.. Am J Hematol. 2014;89(7):695-697.
Amniotic fluid stem cells for the treatment of hemophilia A [abstract]. Kuo C-J, Mokhtari S, Soland M, Soker S, Yoo J, Owen J, Knovich MA, Atala A, Almeida-Porada G, Porada C.. Mol Ther. 2013;21(Suppl 1):S96-S97.
Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements. Knovich MA, Farland A, Owen J.. Eur J Haematol. 2012;88(6):518-525.
BsaXI/RFLP analysis of initial or selectively reamplified PCR product is unreliable in detecting the V617F mutation in JAK2. Shepard GC, Lawson HL, Hawkins GA, Owen J.. Int J Lab Hematol. 2011;33(3):267-271.
Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R Jr, Torti FM, Torti SV.. Biomaterials. 2011;32(26):5970-5978.
Myocardial necrosis in patients with thrombotic thrombocytopenic purpura: pathophysiology and rationale for specific therapy. Sane DC, Streer NP, Owen J.. Eur J Haematol. 2009;82(2):83-92.
Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Wilhelm AJ, Zabalawi M, Grayson JM, Weant AE, Major AS, Owen J, Bharadwaj M, Walzem R, Thomas MJ, Sorci-Thomas MG, et al.. Arterioscler Thromb Vasc Biol. 2009;29(6):843-849.
Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection. Wajih N, Owen J, Wallin R.. Thromb Res. 2008;122(3):405-410.
Rapid quantitative assay of ADAMTS13 activity on an automated coagulation analyzer: clinical applications and comparison with immunoblot method. Knovich MA, Lawson HL, Burke MH, McCoy TP, Owen J.. Am J Hematol. 2008;83(8):654-656.
Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review. Wahla AS, Ruiz J, Noureddine N, Upadhya B, Sane DC, Owen J.. Eur J Haematol. 2008;81(4):311-316.
Link between ADAMTS-13 and troponin levels? [letter]. Sane DC, Owen J.. Crit Care Med. 2008;36(10):2959-2960.
ApoA-I FIN partially prevents cholesterol deposition and inflammation in skin and lymph nodes of diet-fed LDLr-/-, ApoA-I-/- mice [abstract]. Bharadwaj MS, Zabalawi M, Owen JS, Thomas MJ, Zannis VI, Duka A, Sorci-Thomas MG.. Arterioscler Thromb Vasc Biol. 2007;27(6):e-124.
Copper deficiency causes reversible myelodysplasia. Huff JD, Keung Y-K, Thakuri M, Beaty MW, Hurd DD, Owen J, Molnar I.. Am J Hematol. 2007;82(7):625-630.
Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays. Zhang L, Lawson HL, Harish VC, Huff JD, Knovich MA, Owen J.. Anal Biochem. 2006;358(2):298-300.
Isolated antiplasmin deficiency presenting as a spontaneous bleeding disorder in a 63-year-old man. Harish VC, Zhang L, Huff JD, Lawson H, Owen J.. Blood Coagul Fibrinolysis. 2006;17(8):673-675.
A rapid sensitive assay for measuring ADAMTS13 activity in plasma utilizing a novel recombinant Alexa488-vWF86 (Q1599\P1611C) FRET substrate [abstract]. Guinto ER, Grafos N, Owen J, Lawson HL, Greenfield RS.. Blood. 2006;108(11 Pt 2):88b.
Enhanced synthesis of functional recombinant factors IX and VII by BHK cells engineered to overexpress VKORC1 combined with siRNA silencing of the gamma-carboxylation inhibitor calumenin [abstract]. Wallin R, Wajih N, Owen J.. Blood. 2006;108(11 Pt 1):485a.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.